159 related articles for article (PubMed ID: 7913002)
21. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
22. Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Arch Intern Med; 1997 Jan; 157(1):64-9. PubMed ID: 8996042
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Torres RA; Barr M; Thorn M; Gregory G; Kiely S; Chanin E; Carlo C; Martin M; Thornton J
Am J Med; 1993 Dec; 95(6):573-83. PubMed ID: 8018144
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of primary chemoprophylaxis against Pneumocystis carinii pneumonia during the first year of life in infants infected with human immunodeficiency virus type 1.
Rigaud M; Pollack H; Leibovitz E; Kim M; Persaud D; Kaul A; Lawrence R; John DD; Borkowsky W; Krasinski K
J Pediatr; 1994 Sep; 125(3):476-80. PubMed ID: 7915306
[TBL] [Abstract][Full Text] [Related]
25. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS.
Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA
Ann Intern Med; 1992 Jul; 117(2):106-11. PubMed ID: 1351371
[TBL] [Abstract][Full Text] [Related]
26. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Girard PM; Landman R; Gaudebout C; Olivares R; Saimot AG; Jelazko P; Gaudebout C; Certain A; Boué F; Bouvet E
N Engl J Med; 1993 May; 328(21):1514-20. PubMed ID: 8479488
[TBL] [Abstract][Full Text] [Related]
27. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F
Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164
[TBL] [Abstract][Full Text] [Related]
28. A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Goldman M; Cloud GA; Wade KD; Reboli AC; Fichtenbaum CJ; Hafner R; Sobel JD; Powderly WG; Patterson TF; Wheat LJ; Stein DK; Dismukes WE; Filler SG; ;
Clin Infect Dis; 2005 Nov; 41(10):1473-80. PubMed ID: 16231260
[TBL] [Abstract][Full Text] [Related]
29. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, placebo-controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection.
Smith DE; Bell J; Johnson M; Youle M; Gazzard B; Tchamouroff S; Frechette G; Schlech W; Miller S; Spencer D; Seifert W; Peeters M; De Beule K;
HIV Med; 2001 Apr; 2(2):78-83. PubMed ID: 11737382
[TBL] [Abstract][Full Text] [Related]
31. Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.
Kovacs JA; Masur H
Clin Infect Dis; 1992 May; 14(5):1005-9. PubMed ID: 1350925
[TBL] [Abstract][Full Text] [Related]
32. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.
Schuman P; Capps L; Peng G; Vazquez J; el-Sadr W; Goldman AI; Alston B; Besch CL; Vaughn A; Thompson MA; Cobb MN; Kerkering T; Sobel JD
Ann Intern Med; 1997 May; 126(9):689-96. PubMed ID: 9139554
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
34. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
Cohn DL
Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
[TBL] [Abstract][Full Text] [Related]
35. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM; Lindsey JC; Levin MJ;
Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
[TBL] [Abstract][Full Text] [Related]
36. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
37. HIV-related morbidity and mortality in sub-Saharan Africa: opportunities for prevention.
Lange JM
AIDS; 1993 Dec; 7(12):1675-6. PubMed ID: 8286080
[TBL] [Abstract][Full Text] [Related]
38. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
Lange CG; Woolley IJ; Brodt RH
Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
[TBL] [Abstract][Full Text] [Related]
39. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
Powderly WG; Finkelstein D; Feinberg J; Frame P; He W; van der Horst C; Koletar SL; Eyster ME; Carey J; Waskin H
N Engl J Med; 1995 Mar; 332(11):700-5. PubMed ID: 7854376
[TBL] [Abstract][Full Text] [Related]
40. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]